135 related articles for article (PubMed ID: 34823366)
1. Trends in Nasal Spray Prescribing Patterns by Otolaryngologists in the US Medicare Population.
Kim C; Tran E; Kim I; Hur K
Ann Otol Rhinol Laryngol; 2022 Nov; 131(11):1185-1193. PubMed ID: 34823366
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
[TBL] [Abstract][Full Text] [Related]
3. Geographic Variation in Otolaryngologist Intranasal Steroid Prescribing Patterns Among Medicare Beneficiaries.
Wu FM; Ulloa R; Badash I; Hur K
Ann Otol Rhinol Laryngol; 2023 Feb; 132(2):126-132. PubMed ID: 35176893
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
Hampel FC; Ratner PH; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray.
Derendorf H; Munzel U; Petzold U; Maus J; Mascher H; Hermann R; Bousquet J
Br J Clin Pharmacol; 2012 Jul; 74(1):125-33. PubMed ID: 22356350
[TBL] [Abstract][Full Text] [Related]
6. A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.
Donohue JF; Kalberg C; Emmett A; Merchant K; Knobil K
Treat Respir Med; 2004; 3(3):173-81. PubMed ID: 15219176
[TBL] [Abstract][Full Text] [Related]
7. Deposition characteristics of a novel intranasal formulation of azelastine hydrochloride plus fluticasone propionate in an anatomic model of the human nasal cavity.
Meltzer EO; Bachert C; Mayer MJ; Kopietz F; Koltun A; Maus J; D'Addio AD
Allergy Asthma Proc; 2020 Jul; 41(4):265-270. PubMed ID: 32393418
[No Abstract] [Full Text] [Related]
8. Intranasal spray medications for maintenance therapy of allergic rhinitis.
Berger WE; Meltzer EO
Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
Carr WW; Ratner P; Munzel U; Murray R; Price D; Canonica GW; Mullol J; Virchow JC; Lieberman P; Meltzer E; Bachert C
Allergy Asthma Proc; 2012; 33(6):450-8. PubMed ID: 23127291
[TBL] [Abstract][Full Text] [Related]
10. Fluticasone Propionate with Azelastine Versus Standalone Fluticasone Propionate as Nasal Spray in Allergic Rhinitis: A Prospective Comparative Study in a Rural Population of Northern India.
Agrawal A; Shubhanshu K; Ahmad MS
Indian J Otolaryngol Head Neck Surg; 2023 Sep; 75(3):2168-2171. PubMed ID: 37636743
[TBL] [Abstract][Full Text] [Related]
11. Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial.
Berger W; Sher E; Gawchik S; Fineman S
Allergy Asthma Proc; 2018 Mar; 39(2):110-116. PubMed ID: 29490769
[TBL] [Abstract][Full Text] [Related]
12. Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis.
Dockhorn R; Aaronson D; Bronsky E; Chervinsky P; Cohen R; Ehtessabian R; Finn A; Grossman J; Howland W; Kaiser H; Pearlman D; Sublett J; Ratner P; Settipane G; Sim T; Storms W; Webb R; Drda K; Wood C
Ann Allergy Asthma Immunol; 1999 Apr; 82(4):349-59. PubMed ID: 10227333
[TBL] [Abstract][Full Text] [Related]
13. Comparison table: Some nasal sprays for allergic rhinitis.
Med Lett Drugs Ther; 2021 Apr; 63(1622):e66-e71. PubMed ID: 33848283
[No Abstract] [Full Text] [Related]
14. Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial.
Hayden FG; Diamond L; Wood PB; Korts DC; Wecker MT
Ann Intern Med; 1996 Jul; 125(2):89-97. PubMed ID: 8678385
[TBL] [Abstract][Full Text] [Related]
15. Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups.
Berger WE; Fineman SM; Lieberman P; Miles RM
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):535-41. PubMed ID: 10400480
[TBL] [Abstract][Full Text] [Related]
16. Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life.
Georgitis JW; Banov C; Boggs PB; Dockhorn R; Grossman J; Tinkelman D; Roszko P; Wood C
Clin Exp Allergy; 1994 Nov; 24(11):1049-55. PubMed ID: 7874603
[TBL] [Abstract][Full Text] [Related]
17. Cost efficiency of intranasal corticosteroid prescribing patterns in the management of allergic rhinitis.
Reissman D; Price T; Leibman CW
J Manag Care Pharm; 2004 Jan; 10(1 Suppl):S9-13. PubMed ID: 14720101
[TBL] [Abstract][Full Text] [Related]
18. Opioid-limiting legislation and prescribing habits of otolaryngologists among Medicare beneficiaries.
Kim YJ; Kim I; Badash I; West J; Hur K
Laryngoscope Investig Otolaryngol; 2023 Aug; 8(4):921-929. PubMed ID: 37621267
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of Stability-Indicating Impurity Profiling Method for Azelastine Hydrochloride and Fluticasone Propionate in Nasal Spray Product Using HPLC with a UV/PDA Detector.
Musmade B; Korhale R; Sable M; Lokhande S; Padmanabhan S; Bhope S
J AOAC Int; 2023 Jul; 106(4):866-872. PubMed ID: 36929921
[TBL] [Abstract][Full Text] [Related]
20. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group.
Mandl M; Nolop K; Lutsky BN
Ann Allergy Asthma Immunol; 1997 Oct; 79(4):370-8. PubMed ID: 9357385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
